# Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate Cancer

> **NCT00769795** · PHASE2 · COMPLETED · sponsor: **University of Washington** · enrollment: 29 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** IMC-A12
- **DRUG:** Bicalutamide
- **DRUG:** Goserelin

## Key facts

- **NCT ID:** NCT00769795
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2011-08
- **Final completion:** 2011-11
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2017-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00769795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00769795, "Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00769795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*